EMA to review if new 'effects table' for drugs helps HTA bodies in their work
This article was originally published in SRA
Executive Summary
The European Medicines Agency is to ascertain whether the recent introduction of the "effects table" in its assessment reports for drugs is helpful to health technology assessment bodies carrying out relative effectiveness assessments of drugs.